Stockscreener 앱 받기
27.94
0.60%
-0.17
시간 외 거래:
27.89
-0.05
-0.18%
전일 마감가:
$28.11
열려 있는:
$28.02
하루 거래량:
383.57K
Relative Volume:
0.59
시가총액:
$501.17M
수익:
$116.88M
순이익/손실:
$-25.09M
주가수익비율:
-199.57
EPS:
-0.14
순현금흐름:
$-20.74M
1주 성능:
-0.85%
1개월 성능:
-18.35%
6개월 성능:
+65.82%
1년 성능:
+84.54%
1일 변동 폭
$27.75
$28.99
1주일 범위
$26.38
$28.99
52주 변동 폭
$13.57
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
명칭
Rigel Pharmaceuticals
전화
650-624-1100
주소
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
RIGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
27.94 | 504.22M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-04-03 | 재개 | Piper Sandler | Neutral |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-06-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | 개시 | B. Riley Securities | Neutral |
| 2020-11-09 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-11-15 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-09-26 | 재개 | JP Morgan | Overweight |
| 2019-03-01 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-08-27 | 개시 | Citigroup | Buy |
| 2018-05-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 재개 | Piper Jaffray | Overweight |
| 2017-12-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-11-06 | 재개 | H.C. Wainwright | Buy |
| 2017-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-31 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-30 | 재확인 | Piper Jaffray | Overweight |
| 2016-07-13 | 개시 | H.C. Wainwright | Buy |
| 2016-06-13 | 개시 | Piper Jaffray | Overweight |
| 2016-04-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2013-04-08 | 재확인 | Stifel | Buy |
| 2012-11-29 | 개시 | UBS | Neutral |
| 2012-11-06 | 재확인 | Oppenheimer | Outperform |
| 2012-03-26 | 개시 | Canaccord Genuity | Hold |
| 2010-12-10 | 다운그레이드 | MP Advisors | Outperform → Market Perform |
모두보기
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
Why Rigel Pharmaceuticals Inc. stock could see breakout soonVolume Spike & Safe Capital Growth Tips - newser.com
Momentum divergence signals in Rigel Pharmaceuticals Inc. chartJuly 2025 Final Week & Daily Profit Focused Stock Screening - newser.com
Is Rigel Pharmaceuticals Inc. stock a contrarian buyTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
Will Rigel Pharmaceuticals Inc. stock benefit from green energy trendsJuly 2025 Gainers & Safe Entry Momentum Stock Tips - Trung tâm Dự báo KTTV quốc gia
Will Rigel Pharmaceuticals Inc. (RI2) stock profit from fiscal stimulusWeekly Earnings Recap & Stock Timing and Entry Methods - Trung tâm Dự báo KTTV quốc gia
Is this a good reentry point in Rigel Pharmaceuticals Inc.2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Why Rigel Pharmaceuticals Inc. stock is a value investor pickJobs Report & Safe Capital Investment Plans - Trung tâm Dự báo KTTV quốc gia
Rigel Pharmaceuticals Inc. stock volume spike explainedLayoff News & Free Technical Confirmation Trade Alerts - newser.com
What the charts say about Rigel Pharmaceuticals Inc. todayTrend Reversal & Stepwise Swing Trade Plans - newser.com
Is Rigel Pharmaceuticals Inc. stock recession proofQuarterly Profit Summary & Weekly High Conviction Ideas - newser.com
Is Rigel Pharmaceuticals Inc. trending in predictive chart modelsMarket Risk Summary & Capital Efficient Trading Techniques - newser.com
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now? - sharewise.com
Using portfolio simulators with Rigel Pharmaceuticals Inc. includedWeekly Investment Summary & Expert Approved Trade Ideas - newser.com
After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL) - Yahoo Finance
Can Rigel Pharmaceuticals Inc. (RI2) stock double in coming years2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earningsLong Setup & Daily Volume Surge Trade Alerts - newser.com
Volume spikes in Rigel Pharmaceuticals Inc. stock – what they meanTrade Ideas & Weekly High Momentum Picks - newser.com
How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL Investors - Yahoo Finance
Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Key Clinical Milestone for R289 - simplywall.st
Did Rigel's (RIGL) R289 Phase 1b Expansion Just Shift the Company's Pipeline Prospects? - simplywall.st
Is Rigel Pharmaceuticals Inc. stock reversal real or fakeMarket Trend Report & Safe Capital Growth Tips - newser.com
Rigel Pharmaceuticals (NASDAQ:RIGL) Receives "Hold (C+)" Rating from Weiss Ratings - MarketBeat
Rigel Pharmaceuticals stock advances as first patient enrolled in R289 study expansion - Investing.com
Multi factor analysis applied to Rigel Pharmaceuticals Inc.2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
Published on: 2025-10-09 05:05:12 - newser.com
HC Wainwright & Co. Reiterates Rigel Pharmaceuticals (RIGL) Buy Recommendation - Nasdaq
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4%What's Next? - MarketBeat
Rigel Pharmaceuticals (RIGL) Rating Reiterated as 'Buy' by HC Wa - GuruFocus
Rigel Pharmaceuticals' (RIGL) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Rigel Pharmaceuticals, Inc. Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - MarketScreener
Rigel Pharmaceuticals (RIGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):